{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:41:46Z","timestamp":1761100906067,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":3021,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.bbmt.2006.09.004","type":"journal-article","created":{"date-parts":[[2007,1,11]],"date-time":"2007-01-11T07:59:01Z","timestamp":1168502341000},"page":"107-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Allogeneic Stem Cell Transplantation with T Cell-Depleted Grafts for Lymphoproliferative Malignancies"],"prefix":"10.1016","volume":"13","author":[{"given":"Nicolas","family":"Novitzky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valda","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2006.09.004_bib1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2006.09.004_bib2","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1200\/JCO.1992.10.6.942","article-title":"Survival after relapse of low-grade non-Hodgkin\u2019s lymphoma: implications for marrow transplantation","volume":"10","author":"Weisdorf","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2006.09.004_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1200\/JCO.1983.1.1.11","article-title":"Histologic conversion in the non-Hodgkin\u2019s lymphomas","volume":"1","author":"Acker","year":"1983","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2006.09.004_bib4","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1200\/JCO.1997.15.4.1587","article-title":"Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients","volume":"15","author":"Bastion","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2006.09.004_bib5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/1097-0142(197908)44:2<645::AID-CNCR2820440234>3.0.CO;2-Y","article-title":"Histological transformation of non-Hodgkin\u2019s lymphoma: a prospective study","volume":"44","author":"Cullen","year":"1979","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2006.09.004_bib6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1182\/blood.V59.2.258.258","article-title":"Histologic progression in non-Hodgkin\u2019s lymphoma","volume":"59","author":"Hubbard","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.09.004_bib7","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/1097-0142(19840301)53:5<1109::AID-CNCR2820530516>3.0.CO;2-O","article-title":"Malignant lymphomas of follicular center cell origin in humans","volume":"53","author":"Oviatt","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2006.09.004_bib8","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0889-8588(03)00119-9","article-title":"Peripheral T-cell lymphomas: diagnosis and management","volume":"17","author":"Dearden","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.bbmt.2006.09.004_bib9","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1200\/JCO.1994.12.6.1177","article-title":"Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma","volume":"12","author":"Rohatiner","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2006.09.004_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.beha.2004.08.017","article-title":"Conventional allograft and autograft in low grade lymphoma","volume":"18","author":"Avivi","year":"2005","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.bbmt.2006.09.004_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2141.2004.05251.x","article-title":"The role of allogeneic transplantation in non-Hodgkin\u2019s lymphoma","volume":"128","author":"Peggs","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2006.09.004_bib12","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJM199103073241005","article-title":"Graft-versus-host disease","volume":"324","author":"Ferrara","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2006.09.004_bib13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.bmt.1703134","article-title":"Enhanced graft-versus tumor effect following dose-reduced conditioning nd allogeneic transplantation for refractory lymphoid malignancies after high-dose therapy","volume":"28","author":"Mohty","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.004_bib14","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","article-title":"Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukaemia without myeloablative therapy","volume":"89","author":"Giralt","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.09.004_bib15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/14653240310004520","article-title":"Campath-1 Abs \u2018in the bag\u2019 for hematological malignancies: the Cape Town experience","volume":"6","author":"Novitzky","year":"2004","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2006.09.004_bib16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/sj.bmt.1705119","article-title":"Myeloablative conditioning is well tolerated by older patients receiving T-cell-depleted grafts","volume":"36","author":"Novitzky1","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.004_bib17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.7326\/0003-4819-76-2-227","article-title":"Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone","volume":"76","author":"Bagley","year":"1972","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2006.09.004_bib18","series-title":"Update on Treatment for Diffuse Large-Cell Lymphoma","first-page":"71","article-title":"CHOP is curative in thirty percent of patients with large cell lymphoma","author":"Coltman","year":"1986"},{"key":"10.1016\/j.bbmt.2006.09.004_bib19","series-title":"Haematology and Blood Transfusion. Vol 33. Acute Leukemias II","first-page":"428","article-title":"Treatment of adult acute lymphoblastic leukemia","author":"Jacobs","year":"1990"},{"key":"10.1016\/j.bbmt.2006.09.004_bib20","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1093\/annonc\/mdf221","article-title":"Time-intensified dexamethasone\/cisplatin\/cytarabine: an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin\u2019s disease","volume":"13","author":"Josting","year":"2002","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.bbmt.2006.09.004_bib21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/146532401753173990","article-title":"Infectious complications following T-cell depleted haematopoietic stem cell transplantation","volume":"3","author":"Novitzky","year":"2002","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2006.09.004_bib22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/scd.1.1996.5.213","article-title":"The ISHAGE guidelines for CD34+ cell determination by flow cytometry","volume":"5","author":"Sutherland","year":"1996","journal-title":"J Hematother"},{"key":"10.1016\/j.bbmt.2006.09.004_bib23","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1399-0039.1990.tb01767.x","article-title":"The CAMPATH-1 antigen (Cdw 52)","volume":"35","author":"Hale","year":"1990","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.bbmt.2006.09.004_bib24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/146532401753174061","article-title":"Manufacture and quality control of CAMPATH-1 antibodies for clinical trials","volume":"3","author":"Phillips","year":"2001","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2006.09.004_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft vs host disease in human recipients of marrow from HLA matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2006.09.004_bib26","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"Solal-Celigny","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.09.004_bib27","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1097\/00007890-200212150-00012","article-title":"Immune reconstitution at 6 months following T-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome","volume":"74","author":"Novitzky","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2006.09.004_bib28","first-page":"381","article-title":"Malignant lymphoma: a clinicopathologic survey of 618 cases","volume":"18","author":"Gall","year":"1942","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bbmt.2006.09.004_bib29","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1200\/JCO.2003.08.054","volume":"21","author":"Bierman","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2006.09.004_bib30","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/annonc\/mdg200","article-title":"Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin\u2019s lymphoma","volume":"14","author":"Hosing","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bbmt.2006.09.004_bib31","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.2000.18.3.527","article-title":"High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up","volume":"18","author":"Apostolidis","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2006.09.004_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/annonc\/mdf010","article-title":"Allogeneic haematopoietic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens","volume":"13","author":"Bertz","year":"2002","journal-title":"Ann Oncol"},{"issue":"13","key":"10.1016\/j.bbmt.2006.09.004_bib33","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1182\/blood-2001-11-0107","article-title":"Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation","volume":"100","author":"Robinson","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.09.004_bib34","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0140-6736(84)92564-9","article-title":"Elimination of graft vs host disease by in vitro T-cell depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1)","volume":"1","author":"Waldmann","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2006.09.004_bib35","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1046\/j.1365-2141.1998.00539.x","article-title":"Allogeneic bone marrow transplantation with T-cell-depleted marrow grafts for patients with poor-risk relapsed low-grade non-Hodgkin\u2019s lymphoma","volume":"100","author":"Mandigers","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2006.09.004_bib36","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2001.19.17.3766","article-title":"Impact of high-dose chemotherapy on peripheral T-cell lymphomas","volume":"19","author":"Rodriguez","year":"2001","journal-title":"J Clin Oncol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879106006434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879106006434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:27:02Z","timestamp":1761056822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879106006434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S1083879106006434"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2006.09.004","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allogeneic Stem Cell Transplantation with T Cell-Depleted Grafts for Lymphoproliferative Malignancies","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2006.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}